Clinical Trials List
2017-11-01 - 2022-12-31
Phase I/II
Terminated9
ICD-10C79.10
Secondary malignant neoplasm of unspecified urinary organs
ICD-10C79.11
Secondary malignant neoplasm of bladder
ICD-10C79.19
Secondary malignant neoplasm of other urinary organs
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.1
Secondary malignant neoplasm of other urinary organs
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 沈書慧 Division of Radiology
- Mu-Hsin Chang Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Yen-Hwa Chang Division of Urology
- 潘競成 Division of General Surgery
- Tzu-Ping Lin Division of Urology
- Yi-Hsiu Huang Division of Urology
- Tzeon-jye Chiou Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張英勛 Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- See-Tong Pang Division of Urology
- Rita cheng Division of Urology
- 劉忠一 Division of Urology
- Hong-Cheng Gan Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 夏和雄 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Sin-Syue Li Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- Shang-Yin Wu Division of General Internal Medicine
- Yuh-Shyan Tsai Division of Urology
- Che-Yuan Hu Division of Urology
- Ya-Ting Hsu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ching-Chan Lin Division of Hematology & Oncology
- 陳冠亨 Division of Urology
- Po-Jen Hsiao Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Yi-Huei Chang Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Chi-Ping Huang Division of Urology
- Po-Fan Hsieh Division of Urology
- Hsi-Chin Wu Division of Hematology & Oncology
- Chi-Rei Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
261 participants
